No CRD_XRP

Overview

About this study

The primary purpose of this data collection initiative is to support Abbott research and development activities through the evaluation of novel/modified software features, algorithm development/ improvements, and clinically relevant workflows.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Plans to undergo an EP procedure using applicable mapping and ablation catheters (e.g. Advisor™ VL or HD GridX, TactiFlex SE, third-party PFA ablation catheters) on an EnSite™ X system (version 3.1 or later)

  • At least 18 years of age.

Exclusion Criteria:

  • N/A

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/23/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Suraj Kapa, M.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions